Costco stock price dips as dividend lands; investors wait on sales and earnings

Costco stock price dips as dividend lands; investors wait on sales and earnings

New York, Jan 16, 2026, 12:15 EST — Regular session

Costco Wholesale shares edged lower on Friday as investors took in the company’s latest dividend declaration, with the broader market little changed.

The warehouse retailer’s stock was down about 0.1% at $955.35 in midday trade, lagging a flat S&P 500. Walmart and Target were also down, while BJ’s Wholesale slid more than 1%.

The timing matters because Costco’s next monthly sales snapshot is close. The company is scheduled to release January sales results on Feb. 4, an update traders use as an early read on store traffic and demand before the next earnings report. (Costco)

The dividend itself is not a surprise for a steady cash generator, but it keeps the focus on what investors are paying for in retail right now: repeat business, predictable fees and less drama in the numbers.

Costco said its board declared a quarterly cash dividend of $1.30 per share, payable on Feb. 13 to shareholders of record as of Jan. 30. At Friday’s price, that’s an annualized $5.20 dividend, or roughly a 0.5% yield. The company said it operates 923 warehouses worldwide. (Costco)

A separate regulatory filing showed some insider selling. Executive Vice President James C. Klauer sold 1,500 Costco shares at $939 on Jan. 14, a Form 4 filing showed — the document insiders file with the U.S. SEC to disclose stock trades. (SEC)

Wall Street remains split on how much to pay for the name. Bernstein analyst Zhihan Ma argued this week that wide valuation gaps across retailers can be justified by growth and profitability, and described Costco as an “ultimate compounder,” according to a Barron’s report. (Barron’s)

Costco’s monthly sales updates have carried extra weight since the company reported December net sales rose 8.5% to $29.86 billion in the five weeks ended Jan. 4. (Costco)

But the premium multiple cuts both ways. Any sign of softer comparable sales, higher wage and freight costs, or a hit from currency and gasoline price swings could sting a stock that investors often treat as a safe place to hide.

The next hard catalyst is the fiscal second-quarter earnings call on March 5, scheduled after the U.S. market close. (Costco)

Stock Market Today

  • WuXi Biologics seen undervalued after 121% rebound, DCF model shows
    January 16, 2026, 3:17 PM EST. WuXi Biologics (Cayman) trades at HK$39.78 after a 121.5% one-year rebound. The stock rose 7.3% last week and 22.2% over the past month, but shows declines over three years (44.2%) and five years (67.2%). Investors reassess contract development and manufacturing exposure among Hong Kong-listed peers. Simply Wall St gives a valuation score of 4 out of 6, signaling mixed signals. The main signal comes from a DCF (discounted cash flow) model valuing the shares at HK$65.71, implying the stock is about 39.5% below that intrinsic value. The model uses a two-stage free cash flow to equity (FCFE) approach; latest trailing cash flow is CN¥839.36 million, with forecasts rising to 2030. Bottom line: the shares appear undervalued on this framework, though execution risk remains.
Intuitive Machines stock jumps as Morgan Stanley turns bullish on space stocks and LUNR traders weigh Lanteris deal
Previous Story

Intuitive Machines stock jumps as Morgan Stanley turns bullish on space stocks and LUNR traders weigh Lanteris deal

Western Digital stock slips after early swing as analysts lift targets ahead of Jan. 29 results
Next Story

Western Digital stock slips after early swing as analysts lift targets ahead of Jan. 29 results

Go toTop